How Does Patent Eligibility Work for Nutraceutical Products under Us Law?

Автор : Donghoo Sohn, Esq.



Learn how US patent eligibility applies to nutraceutical products and what strategies help protect your formulas against patent rejections. Section 101 of Title 35 places strict limits on natural products, requiring inventors to prove markedly different characteristics. Applicants must demonstrate technical effects and unexpected results to secure strong composition and method claims before the USPTO.

Contents


1. Understanding Patent Eligibility under 35 U.S.C. § 101


Section 101 of Title 35 governs whether an invention falls into patent-eligible subject matter before the USPTO. Patent examiners evaluate whether claims target judicial exceptions like laws of nature, natural phenomena, or abstract ideas. SJKP’s attorneys routinely guide life sciences and dietary supplement companies through these statutory boundaries to safeguard functional health innovations.



The Four-Step Patent Eligibility Framework


Examiners follow a structured test under MPEP § 2106 to assess eligibility. The inquiry first verifies whether a claim matches statutory categories: process, machine, manufacture, or composition of matter. Step 2A Step 1 evaluates whether the claim recites a judicial exception. Step 2A Step 2 determines whether the exception is integrated into a practical application. Step 2B examines if the claim adds significantly more to transform the natural concept into a patent-eligible application.



How Courts Apply Eligibility Standards to Nutraceuticals


Federal courts strictly enforce eligibility limitations when addressing natural extracts and botanical combinations. Judges assess whether claimed formulas differ structurally or functionally from naturally occurring sources. Federal Circuit decisions highlight that minor purifying steps or basic mixing fail to overcome Section 101 rejections without clear technological transformations.



2. The Natural Products Exception and Its Impact


The natural products exception directly impacts dietary supplement manufacturers seeking protection in the United States. Unmodified plant extracts, unrefined chemical compounds, and standard vitamin mixtures face heightened scrutiny. Drawing on our attorneys' combined experience, securing approval requires demonstrating that human intervention modified the substance's fundamental properties.



When Naturally Occurring Ingredients Lose Patent Protection


Isolating a natural compound without altering its inherent function does not confer patentability. A botanical ingredient that performs the same biological role inside a capsule as it does in nature remains ineligible. Applicants cannot patent naturally existing molecules merely by identifying previously unknown health benefits.



Establishing Markedly Different Characteristics


To overcome natural product rejections, applications must prove markedly different characteristics in chemical structure, biological activity, or physical form. Demonstrating altered solubility, superior stability, or unique molecular binding profiles provides strong evidence. Physical changes that create non-naturally occurring functional properties satisfy USPTO standards.



3. Overcoming Uspto Rejections on Eligibility Grounds


Receiving an Office Action under Section 101 requires a strategic legal response rather than minor wording changes. Our firm’s extensive experience shows that early identification of examiner reasoning allows applicants to submit effective amendments and technical evidence.



Common Rejection Patterns in Nutraceutical Applications


Examiners frequently issue subject matter rejections by classifying botanical blends as mere aggregations of natural components. Another frequent pattern involves treating therapeutic dosage claims as unpatentable laws of nature. Recognizing these rejection frameworks helps target specific legal deficiencies during prosecution.



Strengthening Claims Language to Survive Challenges


Overcoming eligibility rejections involves adding specific functional limitations and physical processing parameters to independent claims. Integrating specific delivery mechanisms, synergistic ratios, or chemical modifications shifts the claim focus away from raw natural phenomena toward eligible human-made technical solutions.



4. Patentable Subject Matter Categories for Nutraceuticals


Nutraceutical applications generally rely on two distinct claim types to build comprehensive intellectual property portfolios. Structuring both composition and method claims ensures maximum commercial exclusivity across consumer markets.



Composition of Matter Claims


Composition claims protect specific physical formulations, unique ingredient matrices, and specialized delivery systems. These claims must detail non-natural combinations, modified active compounds, or proprietary liposomal carriers. Defining precise weight ratios helps distinguish claimed compositions from naturally occurring formulations.



Method of Treatment and Use Claims


Method claims focus on administering specific formulation regimens to treat targeted physiological conditions or metabolic pathways. By framing claims around specific therapeutic administration protocols, applicants can establish patent eligibility even when using known natural ingredients.



5. Distinguishing Your Nutraceutical Formula from Prior Art


Surviving Section 101 challenges requires differentiating formulas from existing public disclosures under Sections 102 and 103. Applications must demonstrate distinct technical advantages that prior references do not teach or suggest.



Technical Effects and Unexpected Results


Providing comparative experimental data in the specification establishes both eligibility and non-obviousness. Evidence showing synergistic bioactivity, unexpected bioavailability increases, or significant toxicity reductions proves that the combination produces non-obvious technical results.



Supporting Claims with Robust Specification Language


The specification must contain detailed experimental protocols, clear comparative graphs, and well-documented clinical trial results. SJKP’s attorneys emphasize drafting rich technical disclosures to ensure dependent claims have adequate support when responding to USPTO inquiries.



6. Strategic Claim Drafting for Maximum Protection


Building a resilient patent portfolio requires balancing broad commercial coverage with narrow, defensible fallback positions. A tiered claiming strategy protects against competitor design-arounds while surviving validity challenges.



Independent Vs. Dependent Claims Backed by Scientific Data


Independent claims should establish broad protection over core technical inventive concepts without overly restricting scope. Dependent claims must systematically incorporate narrow operational boundaries, specific synergistic ratios, precise purity metrics, and verified laboratory data. Linking dependent limitations directly to empirical testing safeguards claims during patent re-examination and court litigation.


20 Jan, 2026


Информация, представленная в этой статье, носит исключительно общий информационный характер и не является юридической консультацией. Предыдущие результаты не гарантируют аналогичного исхода. Чтение или использование содержания этой статьи не создает отношений адвокат-клиент с нашей фирмой. За советом по вашей конкретной ситуации, пожалуйста, обратитесь к квалифицированному адвокату, лицензированному в вашей юрисдикции.
Некоторые информационные материалы на этом сайте могут использовать инструменты с технологиями помощи в составлении и подлежат проверке адвокатом.

Связанные практики


Записаться на консультацию
Online
Phone